Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents

American Journal of Cardiology

Volumn 106, Issue 6, 2010, Pages 774-779

  Novack, Victor ^a   Nguyen, Michael C ^b   Rooney, Meredith ^b   Chacko, Riya ^b   Novack, Lena ^a   Pencina, Michael ^a   Apruzzese, Patricia ^a   Mauri, Laura ^a   Cohen, Sidney A ^c,d   Moses, Jeffrey ^e   Leon, Martin B ^e   Cutlip, Donald E ^a,b  

^a HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Department of Medical Affairs and Health Ecomomics Worldwide   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; IMMUNOSUPPRESSIVE AGENT; METAL;

ADULT; AGED; ARTICLE; BARE METAL STENT; BRACHYTHERAPY; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STENT THROMBOSIS; SURVIVOR; THERAPY EFFECT; CONFIDENCE INTERVAL; CORONARY RESTENOSIS; FOLLOW UP; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONFIDENCE INTERVALS; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SIROLIMUS; STENTS; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77956341965     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.04.039     Document Type: Article

References (20)

1. M.S. Chen, J.M. John, D.P. Chew, D.S. Lee, S.G. Ellis, and D.L. Bhatt Bare metal stent restenosis is not a benign clinical entity Am Heart J 151 2006 1260 1264
2. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, C. O'Shaughnessy, R.P. Caputo, D.J. Kereiakes, D.O. Williams, P.S. Teirstein, J.L. Jaeger, and R.E. Kuntz Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
3. G.W. Stone, S.G. Ellis, D.A. Cox, J. Hermiller, C. O'Shaughnessy, J.T. Mann, M. Turco, R. Caputo, P. Bergin, J. Greenberg, J.J. Popma, and M.E. Russell A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
4. B. Lagerqvist, S.K. James, U. Stenestrand, J. Lindback, T. Nilsson, and L. Wallentin Long-term outcomes with drug-eluting stents versus Bare-metal stents in Sweden N Engl J Med 356 2007 1009 1019
5. A.J. Nordmann, M. Briel, and H.C. Bucher Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis Eur Heart J 27 2006 2784 2814
6. E. Camenzind, P.G. Steg, and W. Wijns Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern Circulation 115 2007 1440 1456
7. M. Pfisterer, H.P. Brunner-La Rocca, P.T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, and C. Kaiser Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus Bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
8. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
9. G.W. Stone, J.W. Moses, S.G. Ellis, J. Schofer, K.D. Dawkins, M.C. Morice, A. Colombo, E. Schampaert, E. Grube, A.J. Kirtane, D.E. Cutlip, M. Fahy, S.J. Pocock, R. Mehran, and M.B. Leon Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
10. G.W. Stone, S.G. Ellis, A. Colombo, K.D. Dawkins, E. Grube, D.E. Cutlip, M. Friedman, D.S. Baim, and J. Koglin Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation Circulation 115 2007 2842 2847
11. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, and P.W. Serruys Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
12. K. Thygesen, J.S. Alpert, H.D. White, A.S. Jaffe, F.S. Apple, M. Galvani, H.A. Katus, L.K. Newby, J. Ravkilde, B. Chaitman, P.M. Clemmensen, M. Dellborg, H. Hod, P. Porela, R. Underwood, J.J. Bax, G.A. Beller, R. Bonow, E.E. Van der Wall, J.P. Bassand, W. Wijns, T.B. Ferguson, P.G. Steg, B.F. Uretsky, D.O. Williams, P.W. Armstrong, E.M. Antman, K.A. Fox, C.W. Hamm, E.M. Ohman, M.L. Simoons, P.A. Poole-Wilson, E.P. Gurfinkel, J.L. Lopez-Sendon, P. Pais, S. Mendis, J.R. Zhu, L.C. Wallentin, F. Fernandez-Aviles, K.M. Fox, A.N. Parkhomenko, S.G. Priori, M. Tendera, L.M. Voipio-Pulkki, A. Vahanian, A.J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S.D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J.L. Zamorano, J. Morais, S. Brener, R. Harrington, D. Morrow, M. Lim, M.A. Martinez-Rios, S. Steinhubl, G.N. Levine, W.B. Gibler, D. Goff, M. Tubaro, D. Dudek, and N. Al-Attar Universal definition of myocardial infarction Circulation 116 2007 2634 2653 (Pubitemid 350182388)
13. A. Kastrati, A. Schomig, S. Elezi, H. Schuhlen, J. Dirschinger, M. Hadamitzky, A. Wehinger, J. Hausleiter, H. Walter, and F.J. Neumann Predictive factors of restenosis after coronary stent placement J Am Coll Cardiol 30 1997 1428 1436
14. D.E. Cutlip, M.S. Chauhan, D.S. Baim, K.K. Ho, J.J. Popma, J.P. Carrozza, D.J. Cohen, and R.E. Kuntz Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials J Am Coll Cardiol 40 2002 2082 2089
15. M.B. Leon, P.S. Teirstein, J.W. Moses, P. Tripuraneni, A.J. Lansky, S. Jani, S.C. Wong, D. Fish, S. Ellis, D.R. Holmes, D. Kerieakes, and R.E. Kuntz Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting N Engl J Med 344 2001 250 256
16. R. Waksman, A.E. Ajani, R.L. White, R. Chan, B. Bass, A.D. Pichard, L.F. Satler, K.M. Kent, R. Torguson, R. Deible, E. Pinnow, and J. Lindsay Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis Circulation 109 2004 340 344
17. G.J. Mishkel, A.L. Moore, S. Markwell, M.C. Shelton, and M.E. Shelton Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents J Am Coll Cardiol 49 2007 181 184
18. F. Alfonso, J.M. Auge, J. Zueco, A. Bethencourt, J.R. Lopez-Minguez, J.M. Hernandez, J.A. Bullones, I. Calvo, E. Esplugas, M.J. Perez-Vizcayno, R. Moreno, C. Fernandez, R. Hernandez, and V. Gama-Ribeiro Long-term results (three to five years) of the Restenosis Intrastent: Balloon angioplasty versus elective Stenting (RIBS) randomized study J Am Coll Cardiol 46 2005 756 760
19. H. Schuhlen, A. Kastrati, J. Mehilli, J. Hausleiter, J. Pache, J. Dirschinger, and A. Schomig Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement Am Heart J 147 2004 317 322
20. J. Pache, A. Dibra, C. Schaut, H. Schuhlen, J. Dirschinger, J. Mehilli, A. Kastrati, and A. Schomig Sustained increased risk of adverse cardiac events over 5 years after implantation of gold-coated coronary stents Catheter Cardiovasc Interv 68 2006 690 695